Refractory Malignant Solid Neoplasm

Showing NaN - NaN of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)

Recruiting
  • Atypical Teratoid/Rhabdoid Tumor
  • +17 more
  • Atezolizumab
  • +7 more
  • Birmingham, Alabama
  • +19 more
Feb 2, 2023

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

Recruiting
  • Recurrent Alveolar Rhabdomyosarcoma
  • +7 more
  • Birmingham, Alabama
  • +28 more
Jan 26, 2023

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +124 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +30 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +123 more
Aug 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

Active, not recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +19 more
Jun 29, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
Jun 28, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Recurrent Malignant Solid Tumor, Recurrent Osteosarcoma, Refractory Malignant Solid Tumor Trial in United States (Laboratory

Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +23 more
Apr 22, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
Mar 15, 2022

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

Completed
  • Childhood Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +20 more
Apr 12, 2021